Wang, J.-H. et al. Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination. Cell. Oncol. 46, 465–480 (2023).
Google ScholarÂ
Zhang, S., Xie, B., Zhu, X., Dong, S. & Li, M. Lactylation in cancer: unveiling new layers of complexity. Innovation 6, 100914 (2025).
Google ScholarÂ
Li, X. et al. Lactate metabolism in human health and disease. Signal Transduct. Target. Ther. 7, 305 (2022).
Google ScholarÂ
Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).
Google ScholarÂ
Haas, R. et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 13, e1002202 (2015).
Google ScholarÂ
Chandel, N. S. Glycolysis. Cold Spring Harb. Perspect. Biol. 13, a040535 (2021).
Chelakkot, C., Chelakkot, V. S., Shin, Y. & Song, K. Modulating glycolysis to improve cancer therapy. Int. J. Mol. Sci. 24, 2606 (2023).
Lunt, S. Y. & Vander Heiden, M. G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441–464 (2011).
Google ScholarÂ
Chang, C.-H., Zhou, X.-W., Wang, Y.-C. & Lee, T.-H. Differential effects of hypothermal stress on lactate metabolism in fresh water- and seawater-acclimated milkfish, Chanos chanos. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 248, 110744 (2020).
Google ScholarÂ
Navas, L. E. & Carnero, A. NAD(+) metabolism, stemness, the immune response, and cancer. Signal Transduct. Target. Ther. 6, 2 (2021).
Google ScholarÂ
Kato, G. J. et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107, 2279–2285 (2006).
Google ScholarÂ
Drent, M., Cobben, N. A., Henderson, R. F., Wouters, E. F. & van Dieijen-Visser, M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur. Respir. J. 9, 1736–1742 (1996).
Google ScholarÂ
Carvajal, H. F., Passey, R. B., Berger, M., Travis, L. B. & Lorentz, W. B. Urinary lactic dehydrogenase isoenzyme 5 in the differential diagnosis of kidney and bladder infections. Kidney Int. 8, 176–184 (1975).
Google ScholarÂ
Tsoi, S. C., Zheng, J., Xu, F. & Kay, H. H. Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi. Placenta 22, 317–322 (2001).
Google ScholarÂ
Rotenberg, Z. et al. Alterations in total lactate dehydrogenase and its isoenzyme-5 in hepatic disorders. Ann. Clin. Lab. Sci. 20, 268–273 (1990).
Google ScholarÂ
Karlsson, J., Frith, K., Sjödin, B., Gollnick, P. D. & Saltin, B. Distribution of LDH isozymes in human skeletal muscle. Scand. J. Clin. Lab. Investig. 33, 307–312 (1974).
Google ScholarÂ
Koslowski, M. et al. Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res. 62, 6750–6755 (2002).
Google ScholarÂ
Skude, G., von Eyben, F. E. & Kristiansen, P. Additional lactate dehydrogenase (LDH) isoenzymes in normal testis and spermatozoa of adult man. Mol. Gen. Genet. 198, 172–174 (1984).
Google ScholarÂ
von Eyben, F. E. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors. Clin. Biochem. 34, 441–454 (2001).
Google ScholarÂ
Liu, F., Belding, R., Usategui-Gomez, M. & Reynoso, G. Immunochemical determination of LDH-1. Am. J. Clin. Pathol. 75, 701–707 (1981).
Google ScholarÂ
Mohás, M. et al. Serum total LDH activity and LDH-2 isozyme in nephrotic syndrome. Kidney Blood Press. Res. 31, 47–54 (2008).
Google ScholarÂ
Mediconda, S., Abidullah, M. & Velidandla, S. To evaluate the role of lactate dehydrogenase as biomarker in the progression of potentially malignant disorders in smokers and gutkha chewers. J. Oral. Maxillofac. Pathol. 27, 601 (2023).
Google ScholarÂ
Liao, M. et al. Targeting the warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sin B 14, 953–1008 (2024).
Google ScholarÂ
Walenta, S. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916–921 (2000).
Google ScholarÂ
Kompanje, E. J. O., Jansen, T. C., van der Hoven, B. & Bakker, J. The first demonstration of lactic acid in human blood in shock by Johann Joseph Scherer (1814-1869) in January 1843. Intensive Care Med. 33, 1967–1971 (2007).
Google ScholarÂ
Li, W. et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy 20, 114–130 (2024).
Google ScholarÂ
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., GarcÃa-Carrancá, A. & Manzo-Merino, J. Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front. Oncol. 9, 1143 (2019).
Google ScholarÂ
Wang, Y. & Patti, G. J. The warburg effect: a signature of mitochondrial overload. Trends Cell Biol. 33, 1014–1020 (2023).
Google ScholarÂ
Macchi, C. et al. Monocarboxylate transporter 1 deficiency impacts CD8(+) T lymphocytes proliferation and recruitment to adipose tissue during obesity. iScience 25, 104435 (2022).
Google ScholarÂ
Wang, Y. et al. Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia. Nat. Commun. 10, 201 (2019).
Google ScholarÂ
Yoo, H. C. et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells. Cell Metab. 31, 267–283.e12 (2020).
Google ScholarÂ
van Geldermalsen, M. et al. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene 35, 3201–3208 (2016).
Google ScholarÂ
Zhang, Q. et al. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J. Hepatol. 80, 293–308 (2024).
Google ScholarÂ
Dunn, A., Chenoweth, M. & Schaeffer, L. D. Estimation of glucose turnover and the cori cycle using glucose-6-t-14C. Biochemistry 6, 6–11 (1967).
Google ScholarÂ
Rabinowitz, J. D. & Enerbäck, S. Lactate: the ugly duckling of energy metabolism. Nat. Metab. 2, 566–571 (2020).
Google ScholarÂ
Hui, S. et al. Glucose feeds the TCA cycle via circulating lactate. Nature 551, 115–118 (2017).
Google ScholarÂ
Ferguson, B. S. et al. Lactate metabolism: historical context, prior misinterpretations, and current understanding. Eur. J. Appl. Physiol. 118, 691–728 (2018).
Google ScholarÂ
Sun, S., Li, H., Chen, J. & Qian, Q. Lactic acid: no longer an inert and end-product of glycolysis. Physiology 32, 453–463 (2017).
Google ScholarÂ
Brooks, G. A. The science and translation of lactate shuttle theory. Cell Metab. 27, 757–785 (2018).
Google ScholarÂ
Bonen, A. Lactate transporters (MCT proteins) in heart and skeletal muscles. Med. Sci. Sports Exerc. 32, 778–789 (2000).
Google ScholarÂ
Wang, N. et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell 184, 370–383.e13 (2021).
Google ScholarÂ
Hutcheson, J. et al. Immunologic and metabolic features of pancreatic ductal adenocarcinoma define prognostic subtypes of disease. Clin. Cancer Res. 22, 3606–3617 (2016).
Google ScholarÂ
He, J. et al. MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases. Clin. Transl. Oncol. https://doi.org/10.1007/s12094-024-03720-0 (2024).
Babl, N. et al. MCT4 blockade increases the efficacy of immune checkpoint blockade. J. Immunother. Cancer 11, e007349 (2023).
Niu, Z. et al. MCT4 promotes hepatocellular carcinoma progression by upregulating TRAPPC5 gene. J. Hepatocell. Carcinoma 9, 289–300 (2022).
Google ScholarÂ
Lee, S. H., Hwang, H. K., Lee, W. J. & Kang, C. M. MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer. Cell. Oncol. 44, 1363–1371 (2021).
Google ScholarÂ
Sonveaux, P. et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Investig. 118, 3930–3942 (2008).
Google ScholarÂ
Gao, T., Lin, Y.-Q., Ye, H.-Y. & Lin, W.-M. miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating treg cells and improves ovarian cancer immunotherapy. Neoplasma 70, 713–721 (2023).
Google ScholarÂ
Sonveaux, P. et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS ONE 7, e33418 (2012).
Google ScholarÂ
Végran, F., Boidot, R., Michiels, C., Sonveaux, P. & Feron, O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 71, 2550–2560 (2011).
Google ScholarÂ
Hu, X. et al. Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse warburg effect. Phytomedicine 123, 155214 (2024).
Google ScholarÂ
Yoshida, G. J. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J. Exp. Clin. Cancer Res. 34, 111 (2015).
Google ScholarÂ
Jacobs, R. A., Meinild, A.-K., Nordsborg, N. B. & Lundby, C. Lactate oxidation in human skeletal muscle mitochondria. Am. J. Physiol. Endocrinol. Metab. 304, E686–E694 (2013).
Google ScholarÂ
Im, S. H. et al. Stereocomplex polylactide for drug delivery and biomedical applications: a review. Molecules 26, 2846 (2021).
RACKER, E. The mechanism of action of glyoxalase. J. Biol. Chem. 190, 685–696 (1951).
Google ScholarÂ
Birts, C. N. et al. p53 is regulated by aerobic glycolysis in cancer cells by the CtBP family of NADH-dependent transcriptional regulators. Sci. Signal. 13, eaau9529 (2020).
Kreisberg, R. A., Siegal, A. M. & Owen, W. C. Glucose-lactate interrelationships: effect of ethanol. J. Clin. Investig. 50, 175–185 (1971).
Google ScholarÂ
Li, J., Ma, P., Liu, Z. & Xie, J. L- and D-lactate: Unveiling their hidden functions in disease and health. Cell Commun. Signal. 23, 134 (2025).
Google ScholarÂ
Du, X., Yan, Y., Dai, Y. & Xu, R. Yogurt alleviates cyclophosphamide-induced immunosuppression in mice through D-lactate. Nutrients 16, 1395 (2024).
Xu, J., Wang, M., Li, M., Yang, J. & Yang, L. Paper-based chiral biosensors using enzyme encapsulation in hydrogel network for point-of-care detection of lactate enantiomers. Anal. Chim. Acta 1279, 341834 (2023).
Google ScholarÂ
Hanssen, N. M. J. et al. Plasma methylglyoxal levels are associated with amputations and mortality in severe limb ischemia patients with and without diabetes. Diab. Care 44, 157–163 (2021).
Google ScholarÂ
Maasen, K. et al. Polymorphisms in glyoxalase I gene are not associated with glyoxalase I expression in whole blood or markers of methylglyoxal stress: the CODAM study. Antioxidants 10, 219 (2021).
Wang, L. et al. Fermentation of dihydroxyacetone by engineered Escherichia coli and Klebsiella variicola to products. Proc. Natl. Acad. Sci. USA 115, 4381–4386 (2018).
Google ScholarÂ
Darling, T. N. & Blum, J. J. D-lactate production by Leishmania braziliensis through the glyoxalase pathway. Mol. Biochem. Parasitol. 28, 121–127 (1988).
Google ScholarÂ
Coronado, B. E., Opal, S. M. & Yoburn, D. C. Antibiotic-induced D-lactic acidosis. Ann. Intern. Med. 122, 839–842 (1995).
Google ScholarÂ
Monroe, G. R. et al. Identification of human D lactate dehydrogenase deficiency. Nat. Commun. 10, 1477 (2019).
Google ScholarÂ
Oh, M. S. et al. D-lactic acidosis in a man with the short-bowel syndrome. N. Engl. J. Med. 301, 249–252 (1979).
Google ScholarÂ
Zhang, D. et al. Lysine L-lactylation is the dominant lactylation isomer induced by glycolysis. Nat. Chem. Biol. https://doi.org/10.1038/s41589-024-01680-8 (2024).
Moreno-Yruela, C., Bæk, M., Monda, F. & Olsen, C. A. Chiral posttranslational modification to lysine ε-amino groups. Acc. Chem. Res. 55, 1456–1466 (2022).
Google ScholarÂ
Li, H. et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature 634, 1229–1237 (2024).
Google ScholarÂ
Zong, Z. et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell 187, 2375–2392.e33 (2024).
Google ScholarÂ
Liu, R. et al. Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis. Cell Metab. 37, 377–394.e9 (2025).
Google ScholarÂ
Wang, S. et al. Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. J. Clin. Investig. 134, e176851 (2024).
Xu, Y. & Wan, W. Acetylation in the regulation of autophagy. Autophagy 19, 379–387 (2023).
Google ScholarÂ
Ma, S. et al. Nutrient-driven histone code determines exhausted CD8(+) T cell fates. Science 387, eadj3020 (2025).
Google ScholarÂ
Yang, L. et al. ACSS2 drives senescence-associated secretory phenotype by limiting purine biosynthesis through PAICS acetylation. Nat. Commun. 16, 2071 (2025).
Google ScholarÂ
Zhu, R. et al. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 37, S1550–4131 (2024). 00411-X.
Google ScholarÂ
Zhao, Q. et al. Nonenzymatic lysine D-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responses. Cell Res. 35, 97–116 (2025).
Google ScholarÂ
Iozzo, M., Pardella, E., Giannoni, E. & Chiarugi, P. The role of protein lactylation: A kaleidoscopic post-translational modification in cancer. Mol. Cell S1097-2765, 00142 (2025).
Trujillo, M. N. et al. Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation. Mol. Metab. 81, 101888 (2024).
Google ScholarÂ
Alhujaily, M. Glyoxalase system in breast and ovarian cancers: role of MEK/ERK/SMAD1 pathway. Biomolecules 14, 584 (2024).
Hosoda, F. et al. Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer. Oncogene 34, 1196–1206 (2015).
Google ScholarÂ
Sakamoto, H. et al. Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95, 3214–3218 (2000).
Google ScholarÂ
Romaldi, B. et al. Overexpression of glyoxalase 2 in human breast cancer cells: Implications for cell proliferation and doxorubicin resistance. Int. J. Mol. Sci. 25, 10888 (2024).
Zeng, Q. et al. Effects of the acetyltransferase p300 on tumour regulation from the novel perspective of posttranslational protein modification. Biomolecules 13, 417 (2023).
Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575–580 (2019).
Google ScholarÂ
Yang, L. et al. Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD. J. Hepatol. 81, 651–666 (2024).
Google ScholarÂ
Li, F. et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol. Cancer 23, 90 (2024).
Google ScholarÂ
Castillo, X. et al. A probable dual mode of action for both L- and D-lactate neuroprotection in cerebral ischemia. J. Cereb. Blood Flow. Metab. 35, 1561–1569 (2015).
Google ScholarÂ
Si, W.-Y. et al. Therapeutic potential of microglial SMEK1 in regulating H3K9 lactylation in cerebral ischemia-reperfusion. Commun. Biol. 7, 1701 (2024).
Google ScholarÂ
Xiong, X.-Y. et al. Astrocyte-derived lactate aggravates brain injury of ischemic stroke in mice by promoting the formation of protein lactylation. Theranostics 14, 4297–4317 (2024).
Google ScholarÂ
Wang, C. et al. Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification. Br. J. Pharmacol. 181, 1843–1856 (2024).
Google ScholarÂ
Strachowska, M. & Robaszkiewicz, A. Characteristics of anticancer activity of CBP/p300 inhibitors—features of their classes, intracellular targets and future perspectives of their application in cancer treatment. Pharmacol. Ther. 257, 108636 (2024).
Google ScholarÂ
Julià , A. et al. A genome-wide association study on a southern European population identifies a new Crohn’s disease susceptibility locus at RBX1-EP300. Gut 62, 1440–1445 (2013).
Google ScholarÂ
Liu, S. et al. TPX2 lactylation is required for the cell cycle regulation and hepatocellular carcinoma progression. Life Sci. Alliance 8, e202402978 (2025).
Chen, Y. et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell 187, 294–311.e21 (2024).
Google ScholarÂ
Bradshaw, P. C. Acetyl-CoA metabolism and histone acetylation in the regulation of aging and lifespan. Antioxidants 10, 572 (2021).
Wang, N. et al. Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ. Res. 131, 893–908 (2022).
Google ScholarÂ
Sun, C. et al. Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation. Theranostics 15, 3055–3075 (2025).
Google ScholarÂ
Niu, Z. et al. HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription. Nat. Commun. 15, 3561 (2024).
Google ScholarÂ
Su, Z., Zhang, Y., Tang, J., Zhou, Y. & Long, C. Multifunctional acyltransferase HBO1: a key regulatory factor for cellular functions. Cell. Mol. Biol. Lett. 29, 141 (2024).
Google ScholarÂ
Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663–669 (2024).
Google ScholarÂ
Shi, H. et al. Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma. Autophagy 1–21. https://doi.org/10.1080/15548627.2025.2477385 (2025).
Wang, L. et al. Adsl-produced fumarate increases BECN1 dimethylation to promote autophagy and liver tumor growth. Autophagy. https://doi.org/10.1080/15548627.2025.2481125 (2025).
Jia, M. et al. ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation. Sci. Adv. 9, eadg4993 (2023).
Google ScholarÂ
Sun, W., Jia, M., Feng, Y. & Cheng, X. Lactate is a bridge linking glycolysis and autophagy through lactylation. Autophagy 19, 3240–3241 (2023).
Google ScholarÂ
Bi, S. et al. KAT8-mediated H4K16ac is essential for sustaining trophoblast self-renewal and proliferation via regulating CDX2. Nat. Commun. 15, 5602 (2024).
Google ScholarÂ
Xie, B. et al. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc. Natl. Acad. Sci. USA 121, e2314128121 (2024).
Google ScholarÂ
Yuan, J. et al. The lactate-primed KAT8‒PCK2 axis exacerbates hepatic ferroptosis during ischemia/reperfusion injury by reprogramming OXSM-dependent mitochondrial fatty acid synthesis. Adv. Sci. 12, e2414141 (2025).
Google ScholarÂ
Zou, Y. et al. A feedback loop driven by H4K12 lactylation and HDAC3 in macrophages regulates lactate-induced collagen synthesis in fibroblasts via the TGF-β signaling. Adv. Sci. 12, e2411408 (2025).
Shokrollahi, M. et al. DNA double-strand break-capturing nuclear envelope tubules drive DNA repair. Nat. Struct. Mol. Biol. 31, 1319–1330 (2024).
Google ScholarÂ
Iuzzolino, A., Pellegrini, F. R., Rotili, D., Degrassi, F. & Trisciuoglio, D. The α-tubulin acetyltransferase ATAT1: structure, cellular functions, and its emerging role in human diseases. Cell. Mol. Life Sci. 81, 193 (2024).
Google ScholarÂ
Yan, Q. et al. Lactylation of NAT10 promotes N(4)-acetylcytidine modification on tRNA(ser-CGA-1-1) to boost oncogenic DNA virus KSHV reactivation. Cell Death Differ. 31, 1362–1374 (2024).
Google ScholarÂ
Niu, K. et al. NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis. Redox Biol. 79, 103479 (2025).
Google ScholarÂ
Zong, Z., Ren, J., Yang, B., Zhang, L. & Zhou, F. Emerging roles of lysine lactyltransferases and lactylation. Nat. Cell Biol. 27, 563–574 (2025).
Google ScholarÂ
Ju, J. et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J. Clin. Investig. 134, e174587 (2024).
Xing, Z. et al. High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy. Cell Rep. 44, 115545 (2025).
Google ScholarÂ
West, A. C. & Johnstone, R. W. New and emerging HDAC inhibitors for cancer treatment. J. Clin. Investig. 124, 30–39 (2014).
Google ScholarÂ
Kim, J., Yu, Y. S., Kim, K. I. & Baek, S. H. Transcriptional repression of autophagy and lysosome biogenesis. Autophagy 1–3. https://doi.org/10.1080/15548627.2025.2465404 (2025).
Yang, Z. et al. Lactylation of HDAC1 confers resistance to ferroptosis in colorectal cancer. Adv. Sci. e2408845. https://doi.org/10.1002/advs.202408845 (2025).
Eom, G. H. & Kook, H. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases. Pharmacol. Ther. 143, 168–180 (2014).
Google ScholarÂ
Zhang, J. et al. Discovery of a novel selective PAK1/HDAC6/HDAC10 inhibitor ZMF-25 that induces mitochondrial metabolic breakdown and autophagy-related cell death in triple-negative breast cancer. Research 8, 0670 (2025).
Google ScholarÂ
Bolding, J. E. et al. Substrates and cyclic peptide inhibitors of the oligonucleotide-activated sirtuin 7. Angew. Chem. Int. Ed. Engl. 62, e202314597 (2023).
Google ScholarÂ
Shen, H. et al. Targeting sirtuins for cancer therapy: epigenetics modifications and beyond. Theranostics 14, 6726–6767 (2024).
Google ScholarÂ
Bai, P. et al. HDAC11 displays neuropathological alterations and offers as a novel drug target for alzheimer’s disease. Alzheimers Dement. 21, e14616 (2025).
Google ScholarÂ
Zhang, F. et al. Targeting histone deacetylase 11 with a highly selective inhibitor for the treatment of MASLD. Adv. Sci. e2412903. https://doi.org/10.1002/advs.202412903 (2025).
Moreno-Yruela, C. et al. Class I histone deacetylases (HDAC1–3) are histone lysine delactylases. Sci. Adv. 8, eabi6696 (2022).
Google ScholarÂ
Deng, J. et al. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 16, 193 (2025).
Google ScholarÂ
Zhu, J., Wu, X., Mu, M., Zhang, Q. & Zhao, X. TEC-mediated tRF-31R9J regulates histone lactylation and acetylation by HDAC1 to suppress hepatocyte ferroptosis and improve non-alcoholic steatohepatitis. Clin. Epigenetics 17, 9 (2025).
Google ScholarÂ
He, X. et al. HDAC2-mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in triple-negative breast cancer. Adv. Sci. e2413121. https://doi.org/10.1002/advs.202413121 (2025).
Li, X. et al. TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation. Eur. Heart J. 45, ehae379 (2024).
Gonzatti, M. B. et al. Class I histone deacetylases catalyze lysine lactylation. J Biol Chem 301, 110602 (2025).
Google ScholarÂ
Tsukihara, S. et al. Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer. Oncogene 44, 724–738 (2025).
Google ScholarÂ
Huang, H. et al. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD(+) salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived conditions. Cancer Lett. 588, 216806 (2024).
Google ScholarÂ
Zessin, M. et al. Uncovering robust delactoylase and depyruvoylase activities of HDAC isoforms. ACS Chem. Biol. 17, 1364–1375 (2022).
Google ScholarÂ
Sun, L. et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat. Commun. 14, 6523 (2023).
Google ScholarÂ
Fan, Z. et al. Identification of SIRT3 as an eraser of H4K16la. iScience 26, 107757 (2023).
Google ScholarÂ
Jin, J. et al. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 24, e56052 (2023).
Google ScholarÂ
Hu, X. et al. Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader. Nucleic Acids Res. 52, 5529–5548 (2024).
Google ScholarÂ
Arnaud, O., Le Loarer, F. & Tirode, F. BAFfling pathologies: alterations of BAF complexes in cancer. Cancer Lett. 419, 266–279 (2018).
Google ScholarÂ
Ren, G. et al. Acute depletion of BRG1 reveals its primary function as an activator of transcription. Nat. Commun. 15, 4561 (2024).
Google ScholarÂ
Zhai, G. et al. DPF2 reads histone lactylation to drive transcription and tumorigenesis. Proc. Natl. Acad. Sci. USA 121, e2421496121 (2024).
Google ScholarÂ
Shvedunova, M. & Akhtar, A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 23, 329–349 (2022).
Google ScholarÂ
Cai, H. et al. Lactate activates trained immunity by fueling the tricarboxylic acid cycle and regulating histone lactylation. Nat. Commun. 16, 3230 (2025).
Google ScholarÂ
Xu, Y. et al. Anaerobic metabolism promotes breast cancer survival via histone-3 lysine-18 lactylation mediating PPARD axis. Cell Death Discov. 11, 54 (2025).
Google ScholarÂ
Li, J. et al. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. Cell. Signal. 124, 111468 (2024).
Google ScholarÂ
Yang, Z. et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat. Metab. 5, 61–79 (2023).
Google ScholarÂ
Zhang, N. et al. α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure. Cell Res. 33, 679–698 (2023).
Google ScholarÂ
Li, G. et al. Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metab. 36, 1696–1710.e10 (2024).
Google ScholarÂ
Meng, Q. et al. Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. J. Exp. Clin. Cancer Res. 43, 36 (2024).
Google ScholarÂ
de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41, 374–403 (2023).
Google ScholarÂ
De Martino, M., Rathmell, J. C., Galluzzi, L. & Vanpouille-Box, C. Cancer cell metabolism and antitumour immunity. Nat. Rev. Immunol. 24, 654–669 (2024).
Google ScholarÂ
Guo, W., Duan, Z., Wu, J. & Zhou, B. P. Epithelial-mesenchymal transition promotes metabolic reprogramming to suppress ferroptosis. Semin. Cancer Biol. 112, 20–35 (2025).
Google ScholarÂ
Wang, Z. et al. Novel histone modifications and liver cancer: Emerging frontiers in epigenetic regulation. Clin. Epigenetics 17, 30 (2025).
Google ScholarÂ
Sun, Z. & Zheng, Y. Metabolic diseases in the east asian populations. Nat. Rev. Gastroenterol. Hepatol. https://doi.org/10.1038/s41575-025-01058-8 (2025).
Joost, H.-G. Diabetes and cancer: epidemiology and potential mechanisms. Diab Vasc. Dis. Res. 11, 390–394 (2014).
Google ScholarÂ
Andreucci, E. et al. Extracellular lactic acidosis of the tumor microenvironment drives adipocyte-to-myofibroblast transition fueling the generation of cancer-associated fibroblasts. Cells 12, 939 (2023).
Du, D. et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm. Sin. B 12, 558–580 (2022).
Google ScholarÂ
Ma, Y.-L. et al. Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study. Front. Endocrinol. 14, 1133991 (2023).
Google ScholarÂ
Zhang, S. et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct. Target. Ther. 9, 149 (2024).
Google ScholarÂ
Moolgavkar, S. H. & Luebeck, E. G. Multistage carcinogenesis: population-based model for colon cancer. J. Natl. Cancer Inst. 84, 610–618 (1992).
Google ScholarÂ
Yang, J. et al. Preferential CEBP binding to T:G mismatches and increased C-to-T human somatic mutations. Nucleic Acids Res. 49, 5084–5094 (2021).
Google ScholarÂ
Kunkel, T. A. Mutational specificity of depurination. Proc. Natl. Acad. Sci. USA 81, 1494–1498 (1984).
Google ScholarÂ
Ullah, A. et al. Cephalomannine inhibits hypoxia-induced cellular function via the suppression of APEX1/HIF-1α interaction in lung cancer. Cell Death Dis. 12, 490 (2021).
Google ScholarÂ
Malik, R. et al. Cryo-EM structure of translesion DNA synthesis polymerase ζ with a base pair mismatch. Nat. Commun. 13, 1050 (2022).
Google ScholarÂ
Lee, Y., Gu, S. & Al-Hashimi, H. M. Insights into the a-C mismatch conformational ensemble in duplex DNA and its role in genetic processes through a structure-based review. J. Mol. Biol. 436, 168710 (2024).
Google ScholarÂ
Zhu, Y. et al. Inhibition of PINK1 senses ROS signaling to facilitate neuroblastoma cell pyroptosis. Autophagy 1–20. https://doi.org/10.1080/15548627.2025.2487037 (2025).
Cai, M. et al. Empowering mitochondrial metabolism: exploring L-lactate supplementation as a promising therapeutic approach for metabolic syndrome. Metabolism 152, 155787 (2024).
Google ScholarÂ
GarcÃa-Giménez, J. L. et al. Oxidative stress and central metabolism pathways impact epigenetic modulation in inflammation and immune response. Free Radic. Biol. Med. 233, 378–399 (2025).
Google ScholarÂ
Hashimoto, T., Hussien, R., Oommen, S., Gohil, K. & Brooks, G. A. Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis. FASEB J. 21, 2602–2612 (2007).
Google ScholarÂ
Liu, X.-L. et al. Emerging therapeutic strategies for metastatic uveal melanoma: targeting driver mutations. Pigment Cell Melanoma Res. 37, 411–425 (2024).
Google ScholarÂ
Pon, J. R. & Marra, M. A. Driver and passenger mutations in cancer. Annu. Rev. Pathol. 10, 25–50 (2015).
Google ScholarÂ
Knudson, A. G. J. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820–823 (1971).
Google ScholarÂ
Prior, I. A., Hood, F. E. & Hartley, J. L. The frequency of Ras mutations in cancer. Cancer Res. 80, 2969–2974 (2020).
Google ScholarÂ
Joerger, A. C., Stiewe, T. & Soussi, T. TP53: The unluckiest of genes? Cell Death Differ. 32, 219–224 (2025).
Google ScholarÂ
Chen, H.-J. et al. SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer. Cancer Lett. 597, 217070 (2024).
Google ScholarÂ
Zhu, J. & Zhang, Y. Dexmedetomidine inhibits the migration, invasion, and glycolysis of glioblastoma cells by lactylation of c-myc. Neurol. Res. 46, 1105–1112 (2024).
Google ScholarÂ
Dai, J. et al. NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer. Mol. Cancer 24, 79 (2025).
Google ScholarÂ
Constâncio, V., Lobo, J., Sequeira, J. P., Henrique, R. & Jerónimo, C. Prostate cancer epigenetics—from pathophysiology to clinical application. Nat. Rev. Urol. https://doi.org/10.1038/s41585-024-00991-8 (2025).
Nohesara, S., Abdolmaleky, H. M. & Thiagalingam, S. Potential for new therapeutic approaches by targeting lactate and pH mediated epigenetic dysregulation in major mental diseases. Biomedicines 12, 457 (2024).
Zhang, L., Wang, X., Zhou, S. & Feng, Y. LDHA enhances brain injury and apoptosis after intracerebral hemorrhage by promoting P53 transcription through increasing P53 lactylation. Brain Res. Bull. 224, 111292 (2025).
Google ScholarÂ
Liu, X. & Wang, B. Histone lactylation regulates autophagy of hyperplastic scar fibroblasts by inhibiting the transcriptional activity of phosphatase and tensin homologue. Wound Repair Regen 32, 725–734 (2024).
Google ScholarÂ
Zeng, Y. et al. Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN. Cell Death Dis. 16, 59 (2025).
Google ScholarÂ
Cai, L.-Y. et al. Targeting p300/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism. Cancer Res. 81, 860–872 (2021).
Google ScholarÂ
Tasselli, L. et al. SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence. Nat. Struct. Mol. Biol. 23, 434–440 (2016).
Google ScholarÂ
Ma, H. et al. A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Mol. Cancer 19, 4 (2020).
Google ScholarÂ
Wang, H. et al. Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma. Cell Rep. 43, 115015 (2024).
Google ScholarÂ
Yang, W. et al. A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma. Sci. Transl. Med. 13, eaaz6804 (2021).
Google ScholarÂ
Okui, T. et al. Lactate secreted via MCT4 from bone‑colonizing breast cancer excites sensory neurons via GPR81. Int. J. Oncol. 62, 39 (2023).
Google ScholarÂ
Zhang, B. et al. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells. Clin. Epigenetics 12, 47 (2020).
Google ScholarÂ
Tang, L. et al. Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance. Cell Commun. Signal. 22, 513 (2024).
Google ScholarÂ
Xu, X. et al. The landscape of N(6)-methyladenosine in localized primary prostate cancer. Nat. Genet. https://doi.org/10.1038/s41588-025-02128-y (2025).
Du, W. et al. Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling. Cancer Lett. 611, 217426 (2024).
Google ScholarÂ
Li, W. et al. Lactylation of RNA m(6)a demethylase ALKBH5 promotes innate immune response to DNA herpesviruses and mpox virus. Proc. Natl. Acad. Sci. USA 121, e2409132121 (2024).
Google ScholarÂ
Yuan, X., Wang, Q., Zhao, J., Xie, H. & Pu, Z. The m6A methyltransferase METTL3 modifies Kcnk6 promoting on inflammation associated carcinogenesis is essential for colon homeostasis and defense system through histone lactylation dependent YTHDF2 binding. Int. Rev. Immunol. 44, 1–16 (2025).
Google ScholarÂ
Chen, T. et al. NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 35, 1782–1798.e8 (2023).
Google ScholarÂ
Wu, H. et al. RNA modifications in cancer. MedComm 6, e70042 (2025).
Google ScholarÂ
Chen, B. et al. Metabolic recoding of NSUN2-mediated m(5)C modification promotes the progression of colorectal cancer via the NSUN2/YBX1/m(5)C-ENO1 positive feedback loop. Adv. Sci. 11, e2309840 (2024).
Google ScholarÂ
Marjanovic, N. D., Weinberg, R. A. & Chaffer, C. L. Cell plasticity and heterogeneity in cancer. Clin. Chem. 59, 168–179 (2013).
Google ScholarÂ
Zheng, B. et al. High sugar induced RCC2 lactylation drives breast cancer tumorigenicity through upregulating MAD2L1. Adv. Sci. e2415530. https://doi.org/10.1002/advs.202415530 (2025).
Llibre, A., Kucuk, S., Gope, A., Certo, M. & Mauro, C. Lactate: a key regulator of the immune response. Immunity 58, 535–554 (2025).
Google ScholarÂ
Gu, X.-Y. et al. Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Front. Immunol. 16, 1563303 (2025).
Google ScholarÂ
Boufaied, N. et al. Obesogenic high-fat diet and MYC cooperate to promote lactate accumulation and tumor microenvironment remodeling in prostate cancer. Cancer Res. 84, 1834–1855 (2024).
Google ScholarÂ
Girgis, H. et al. Lactate dehydrogenase a is a potential prognostic marker in clear cell renal cell carcinoma. Mol. Cancer 13, 101 (2014).
Google ScholarÂ
Xu, H. et al. Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites. Phytomedicine 118, 154940 (2023).
Google ScholarÂ
Javid, H. et al. Probiotics as an adjuvant for management of gastrointestinal cancers through their anti-inflammatory effects: a mechanistic review. Curr. Med. Chem. 30, 390–406 (2023).
Google ScholarÂ
Sheban, F. et al. ZEB2 is a master switch controlling the tumor-associated macrophage program. Cancer Cell 43, 1227–1241.e11 (2025).
Google ScholarÂ
Masmoudi, D., Villalba, M. & Alix-Panabières, C. Natural killer cells: the immune frontline against circulating tumor cells. J. Exp. Clin. Cancer Res. 44, 118 (2025).
Google ScholarÂ
Bhandarkar, V., Dinter, T. & Spranger, S. Architects of immunity: how dendritic cells shape CD8(+) T cell fate in cancer. Sci. Immunol. 10, eadf4726 (2025).
Google ScholarÂ
Cao, L., Shi, X., Chang, H., Zhang, Q. & He, Y. pH-dependent recognition of apoptotic and necrotic cells by the human dendritic cell receptor DEC205. Proc. Natl. Acad. Sci. USA 112, 7237–7242 (2015).
Google ScholarÂ
Stryhn, A. et al. pH dependence of MHC class I-restricted peptide presentation. J. Immunol. 156, 4191–4197 (1996).
Google ScholarÂ
Sangsuwan, R. et al. Lactate exposure promotes immunosuppressive phenotypes in innate immune cells. Cell. Mol. Bioeng. 13, 541–557 (2020).
Google ScholarÂ
Sanmarco, L. M. et al. Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells. Nature 620, 881–889 (2023).
Google ScholarÂ
Plebanek, M. P. et al. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Sci. Immunol. 9, eadi4191 (2024).
Google ScholarÂ
Niveau, C. et al. MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma. Nat. Commun. 16, 1083 (2025).
Google ScholarÂ
Adamik, J. et al. Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients. Nat. Commun. 14, 7211 (2023).
Google ScholarÂ
Sui, X. & Xi, X. MCT1 gene silencing enhances the immune effect of dendritic cells on cervical cancer cells. Adv. Clin. Exp. Med. 33, 739–749 (2024).
Google ScholarÂ
Nasi, A. & Rethi, B. Disarmed by density: a glycolytic break for immunostimulatory dendritic cells? Oncoimmunology 2, e26744 (2013).
Google ScholarÂ
Erdman, S. E. & Poutahidis, T. Cancer inflammation and regulatory T cells. Int. J. Cancer 127, 768–779 (2010).
Google ScholarÂ
Gebhardt, K. et al. Respiratory and metabolic responses of CD4 + T cells to acute exercise and their association with cardiorespiratory fitness. Med. Sci. Sports Exerc. 56, 1882–1892 (2024).
Google ScholarÂ
Decking, S.-M. et al. LDHB overexpression can partially overcome T cell inhibition by lactic acid. Int. J. Mol. Sci. 23, 5970 (2022).
Kumar, A. et al. Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function. Proc. Natl. Acad. Sci. USA 116, 7439–7448 (2019).
Google ScholarÂ
Comito, G. et al. Lactate modulates CD4(+) T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis. Oncogene 38, 3681–3695 (2019).
Google ScholarÂ
Fan, W. et al. Global lactylome reveals lactylation-dependent mechanisms underlying T(H)17 differentiation in experimental autoimmune uveitis. Sci. Adv. 9, eadh4655 (2023).
Google ScholarÂ
Pradenas, C. et al. Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells. Stem Cell Res. Ther. 14, 335 (2023).
Google ScholarÂ
Yu, J. et al. Irradiated lactic acid-stimulated tumour cells promote the antitumour immunity as a therapeutic vaccine. Cancer Lett. 469, 367–379 (2020).
Google ScholarÂ
Xu, L., Ye, L. & Huang, Q. Tissue-resident memory CD8+ T cells: differentiation, phenotypic heterogeneity, biological function, disease, and therapy. MedComm 6, e70132 (2025).
Google ScholarÂ
Viel, S., Vivier, E., Walzer, T. & Marçais, A. Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer. Nat. Rev. Drug Discov. 24, 190–208 (2025).
Google ScholarÂ
Wang, K.-X., Shi, D.-M., Shi, X.-L., Wang, J.-Y. & Ai, X.-H. Obesity promotes immunotherapy efficacy by up-regulating the glycolytic-mediated histone lactacylation modification of CD8+ T cells. Front. Pharmacol. 16, 1533464 (2025).
Google ScholarÂ
Naik, A., Thomas, R., Al-Khalifa, A., Qasem, H. & Decock, J. Immunomodulatory effects of tumor lactate dehydrogenase C (LDHC) in breast cancer. Cell Commun. Signal. 23, 145 (2025).
Google ScholarÂ
Tian, Y. et al. Exosomal PD-L1 and lactate versus tissue PD-L1 as biomarkers for clinical outcomes of PD-1 blockade plus chemotherapy in metastatic esophagogastric signet ring cell carcinoma. Exp. Hematol. Oncol. 14, 34 (2025).
Google ScholarÂ
Ding, C.-H. et al. PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma. Cell Death Dis. 16, 158 (2025).
Google ScholarÂ
Ma, Z. et al. Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. Theranostics 15, 2338–2359 (2025).
Google ScholarÂ
Xu, Q. et al. Intrinsic STING of CD8+ T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects. Cell Commun. Signal. CCS 23, 99 (2025).
Google ScholarÂ
He, J. et al. The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer. Nat. Immunol. 26, 391–403 (2025).
Google ScholarÂ
Peralta, R. M. et al. Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat. Immunol. 25, 2297–2307 (2024).
Google ScholarÂ
Liu, Y. et al. Activation and antitumor immunity of CD8(+) T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid. Sci. Transl. Med. 16, eadk7399 (2024).
Google ScholarÂ
Ma, J. et al. Lithium carbonate revitalizes tumor-reactive CD8(+) T cells by shunting lactic acid into mitochondria. Nat. Immunol. 25, 552–561 (2024).
Google ScholarÂ
Raychaudhuri, D. et al. Histone lactylation drives CD8(+) T cell metabolism and function. Nat. Immunol. 25, 2140–2151 (2024).
Google ScholarÂ
Deng, G. et al. Foxp3 post-translational modifications and Treg suppressive activity. Front. Immunol. 10, 2486 (2019).
Google ScholarÂ
Liu, C. et al. Treg cells promote the SREBP1-dependent metabolic fitness of tumor-promoting macrophages via repression of CD8(+) T cell-derived interferon-γ. Immunity 51, 381–397.e6 (2019).
Google ScholarÂ
Tanaka, A. & Sakaguchi, S. Targeting treg cells in cancer immunotherapy. Eur. J. Immunol. 49, 1140–1146 (2019).
Google ScholarÂ
de Kivit, S. et al. Stable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation. Nat. Metab. 2, 1046–1061 (2020).
Google ScholarÂ
Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Rep. 39, 110986 (2022).
Google ScholarÂ
Tuomela, K. & Levings, M. K. Acidity promotes the differentiation of immunosuppressive regulatory T cells. Eur. J. Immunol. 53, e2350511 (2023).
Google ScholarÂ
Good, Z. et al. Post-infusion CAR T(reg) cells identify patients resistant to CD19-CAR therapy. Nat. Med. 28, 1860–1871 (2022).
Google ScholarÂ
Sabag, B. et al. Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity. EMBO J. 43, 2552–2581 (2024).
Google ScholarÂ
Hui, X. et al. GPR132 regulates the function of NK cells through the gαs/CSK/ZAP70/NF-κB signaling pathway as a potential immune checkpoint. Sci. Adv. 11, eadr9395 (2025).
Google ScholarÂ
Gong, C. et al. IL-6-driven autocrine lactate promotes immune escape of uveal melanoma. Investig. Ophthalmol. Vis. Sci. 65, 37 (2024).
Google ScholarÂ
Wu, S. et al. Lactate efflux inhibition by syrosingopine/LOD co-loaded nanozyme for synergetic self-replenishing catalytic cancer therapy and immune microenvironment remodeling. Adv. Sci. 10, e2300686 (2023).
Google ScholarÂ
Luo, Z. et al. Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression. Cancer Biol. Med. 21, 513–540 (2024).
Google ScholarÂ
Guo, X. et al. NAD + salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity. Hepatology 78, 468–485 (2023).
Google ScholarÂ
Dodard, G. et al. Inflammation-induced lactate leads to rapid loss of hepatic tissue-resident NK cells. Cell Rep. 32, 107855 (2020).
Google ScholarÂ
Ma, J. et al. A blueprint for tumor-infiltrating B cells across human cancers. Science 384, eadj4857 (2024).
Google ScholarÂ
Sharma, R. et al. Distinct metabolic requirements regulate B cell activation and germinal center responses. Nat. Immunol. 24, 1358–1369 (2023).
Google ScholarÂ
Li, K. et al. B cells from old mice induce the generation of inflammatory T cells through metabolic pathways. Mech. Ageing Dev. 209, 111742 (2023).
Google ScholarÂ
Romero, M. et al. Immunometabolic effects of lactate on humoral immunity in healthy individuals of different ages. Nat. Commun. 15, 7515 (2024).
Google ScholarÂ
Nishida, A. & Andoh, A. The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis. Cells 14, 488 (2025).
Google ScholarÂ
Lacina, L., Kolář, M., Pfeiferová, L., Gál, P. & Smetana, K. J. Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation. Front. Immunol. 15, 1403570 (2024).
Google ScholarÂ
Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650–1659 (1986).
Google ScholarÂ
Chattopadhyay, I., Ambati, R. & Gundamaraju, R. Exploring the crosstalk between inflammation and epithelial-mesenchymal transition in cancer. Mediat. Inflamm. 2021, 9918379 (2021).
Google ScholarÂ
Guinn, S. et al. Transfer learning reveals cancer-associated fibroblasts are associated with epithelial-mesenchymal transition and inflammation in cancer cells in pancreatic ductal adenocarcinoma. Cancer Res. 84, 1517–1533 (2024).
Google ScholarÂ
Wilson, A. J., Saskowski, J., Barham, W., Khabele, D. & Yull, F. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer. Mol. Cancer 14, 192 (2015).
Google ScholarÂ
Yang, J. & Xing, Z. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion. Exp. Biol. Med. 246, 1928–1937 (2021).
Google ScholarÂ
Qin, Y. et al. The heterogeneous roles of neutrophils in gastric cancer: Scaffold or target? Cell. Mol. Biol. Lett. 30, 71 (2025).
Google ScholarÂ
Chia, J. W. K. et al. Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): An international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol. Hepatol. 10, 198–209 (2025).
Google ScholarÂ
Pucino, V. et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metabolic rewiring. Cell Metab. 30, 1055–1074.e8 (2019).
Google ScholarÂ
Zeng, W. et al. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming. J. Exp. Clin. Cancer Res. 42, 245 (2023).
Google ScholarÂ
Wang, L., Li, S., Luo, H., Lu, Q. & Yu, S. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages. J. Exp. Clin. Cancer Res. 41, 303 (2022).
Google ScholarÂ
Zhou, Z. et al. Crizotinib: a novel strategy to reverse immunosuppression in melanoma by targeting lactate transport. MedComm 6, e70286 (2025).
Google ScholarÂ
Deng, X. et al. Histone lactylation regulates PRKN-mediated mitophagy to promote M2 macrophage polarization in bladder cancer. Int. Immunopharmacol. 148, 114119 (2025).
Google ScholarÂ
Huang, C., Xue, L., Lin, X., Shen, Y. & Wang, X. Histone lactylation-driven GPD2 mediates M2 macrophage polarization to promote malignant transformation of cervical cancer progression. DNA Cell Biol. 43, 605–618 (2024).
Google ScholarÂ
Lin, J. et al. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma. J. Exp. Clin. Cancer Res. 42, 339 (2023).
Google ScholarÂ
Su, Z. et al. Lactylation-driven ALKBH5 diminishes macrophage NLRP3 inflammasome activation in patients with G6PT deficiency. J. Allergy Clin. Immunol. 155, 1783–1799.e8 (2025).
Google ScholarÂ
Chen, L. et al. Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis. Theranostics 14, 4256–4277 (2024).
Google ScholarÂ
Mukherjee, A. & Bravo-Cordero, J. J. Regulation of dormancy during tumor dissemination: the role of the ECM. Cancer Metastasis Rev. 42, 99–112 (2023).
Google ScholarÂ
Mohan, V., Das, A. & Sagi, I. Emerging roles of ECM remodeling processes in cancer. Semin. Cancer Biol. 62, 192–200 (2020).
Google ScholarÂ
Tomos, I., Kanellopoulou, P., Nastos, D. & Aidinis, V. Pharmacological targeting of ECM homeostasis, fibroblast activation and invasion for the treatment of pulmonary fibrosis. Expert Opin. Ther. Targets 29, 43–57 (2025).
Google ScholarÂ
Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174–186 (2020).
Google ScholarÂ
Wang, D.-H. et al. Single-cell sequencing and multiple machine learning algorithms to identify key T-cell differentiation gene for progression of NAFLD cirrhosis to hepatocellular carcinoma. Front. Mol. Biosci. 11, 1301099 (2024).
Google ScholarÂ
Simon, Y., Kessler, S. M., Bohle, R. M., Haybaeck, J. & Kiemer, A. K. The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC? Gut 63, 861–863 (2014).
Google ScholarÂ
Zhou, Y. et al. The m(6)a reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis. Cell Death Dis. 15, 189 (2024).
Google ScholarÂ
Lei, Y. et al. Senescent lung fibroblasts in idiopathic pulmonary fibrosis facilitate non-small cell lung cancer progression by secreting exosomal MMP1. Oncogene 44, 769–781 (2025).
Google ScholarÂ
Wang, P. et al. H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP. J. Hazard. Mater. 461, 132582 (2024).
Google ScholarÂ
Liu, C. et al. GLP-1R activation attenuates the progression of pulmonary fibrosis via disrupting NLRP3 inflammasome/PFKFB3-driven glycolysis interaction and histone lactylation. J. Transl. Med. 22, 954 (2024).
Google ScholarÂ
Sun, X. et al. Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling. Gut. https://doi.org/10.1136/gutjnl-2024-333638 (2025).
Zhang, Y. et al. Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy. J. Control. Release 381, 113606 (2025).
Google ScholarÂ
Wang, Y. et al. Targeting src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology 80, 578–594 (2024).
Google ScholarÂ
Xu, J. et al. Single-cell transcriptomics reveals the aggressive landscape of high-grade serous carcinoma and therapeutic targets in tumor microenvironment. Cancer Lett. 593, 216928 (2024).
Google ScholarÂ
Kunou, S. et al. Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma. Oncogene 40, 3989–4003 (2021).
Google ScholarÂ
Li, T. et al. Cancer-associated fibroblasts foster a high-lactate microenvironment to drive perineural invasion in pancreatic cancer. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-24-3173 (2025).
Jena, B. C. et al. TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation. Exp. Cell Res. 417, 113195 (2022).
Google ScholarÂ
Affinito, A. et al. MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p. Cell Death Discov. 10, 140 (2024).
Google ScholarÂ
Martinez-Outschoorn, U. E., Lisanti, M. P. & Sotgia, F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin. Cancer Biol. 25, 47–60 (2014).
Google ScholarÂ
Sun, K. et al. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling. EBioMedicine 41, 370–383 (2019).
Google ScholarÂ
Lu, Y. et al. Crosstalk between cancer-associated fibroblasts and non-neuroendocrine tumor cells in small cell lung cancer involves in glycolysis and antigen-presenting features. Mol. Med. 30, 274 (2024).
Google ScholarÂ
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11–20 (2008).
Google ScholarÂ
Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182–1186 (1971).
Google ScholarÂ
Zhang, L. et al. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. J. Hepatol. 80, 82–98 (2024).
Google ScholarÂ
van Noorden, C. J. F. et al. New insights in ATP synthesis as therapeutic target in cancer and angiogenic ocular diseases. J. Histochem. Cytochem. 72, 329–352 (2024).
Google ScholarÂ
Davern, M. et al. Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients. Cancer Immunol. Immunother. 72, 55–71 (2023).
Google ScholarÂ
D’Arcangelo, D., Gaetano, C. & Capogrossi, M. C. Acidification prevents endothelial cell apoptosis by axl activation. Circ. Res. 91, e4–e12 (2002).
Google ScholarÂ
Ye, J. et al. Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma. Research 7, 0387 (2024).
Google ScholarÂ
Brown, T. P. & Ganapathy, V. Lactate/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and warburg phenomenon. Pharmacol. Ther. 206, 107451 (2020).
Google ScholarÂ
He, B. et al. Endothelial OX40 activation facilitates tumor cell escape from T cell surveillance through S1P/YAP-mediated angiogenesis. J. Clin. Investig. 135, e186291 (2025).
Fan, W. et al. A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. Genome Biol. 25, 165 (2024).
Mondal, L. K., Bhaduri, G. & Bhattacharya, B. Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus. Indian J. Ophthalmol. 66, 535–540 (2018).
Google ScholarÂ
Deng, F. et al. Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer. Theranostics 9, 1001–1014 (2019).
Google ScholarÂ
Rundhaug, J. E. Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9, 267–285 (2005).
Google ScholarÂ
Gu, Y. et al. MicroRNAs in tumor endothelial cells: Regulation, function and therapeutic applications. Cells 12, 1692 (2023).
Liu, S. et al. The interaction between vasculogenic mimicry and the immune system: Mechanistic insights and dual exploration in cancer therapy. Cell Prolif. e13814. https://doi.org/10.1111/cpr.13814 (2025).
Zhang, M. et al. Pseudogene MAPK6P4-encoded functional peptide promotes glioblastoma vasculogenic mimicry development. Commun. Biol. 6, 1059 (2023).
Google ScholarÂ
Zhao, R. et al. RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial-mesenchymal transition. Cancer Metab. 12, 32 (2024).
Google ScholarÂ
Li, Z. et al. CAF-secreted LOX promotes PD-L1 expression via histone lactylation and regulates tumor EMT through TGFβ/IGF1 signaling in gastric cancer. Cell. Signal. 124, 111462 (2024).
Google ScholarÂ
Huimin, W. et al. Lactate promotes the epithelial-mesenchymal transition of liver cancer cells via TWIST1 lactylation. Exp. Cell Res. 447, 114474 (2025).
Google ScholarÂ
Wan, X., Li, F., Li, Z. & Zhou, L. ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells. Cell Commun. Signal. 22, 388 (2024).
Google ScholarÂ
Feng, J. et al. LPS-induced monocarboxylate transporter-1 inhibition facilitates lactate accumulation triggering epithelial-mesenchymal transformation and pulmonary fibrosis. Cell. Mol. Life Sci. 81, 206 (2024).
Google ScholarÂ
Wang, K.-X., Du, G.-H., Qin, X.-M. & Gao, L. Compound kushen injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-myc signaling. Phytomedicine 93, 153781 (2021).
Google ScholarÂ
Duan, X. et al. Photothermal-starvation therapy nanomodulator capable of inhibiting colorectal cancer recurrence and metastasis by energy metabolism reduction. Adv. Healthc. Mater. 12, e2300968 (2023).
Google ScholarÂ
Abou Khouzam, R. et al. Tumor hypoxia regulates immune escape/invasion: Influence on angiogenesis and potential impact of hypoxic biomarkers on cancer therapies. Front. Immunol. 11, 613114 (2020).
Google ScholarÂ
Gu, W. et al. NAT1 inhibits liver metastasis of colorectal cancer by regulating EMT and glycolysis. Aging 16, 10546–10562 (2024).
Google ScholarÂ
Cantelmo, A. R. et al. Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy. Cancer Cell 30, 968–985 (2016).
Google ScholarÂ
Nakanishi, M. et al. Acid-sensing receptor GPR4 plays a crucial role in lymphatic cancer metastasis. Cancer Sci. 115, 1551–1563 (2024).
Google ScholarÂ
Liu, Z. et al. Tumor vasculatures: a new target for cancer immunotherapy. Trends Pharmacol. Sci. 40, 613–623 (2019).
Google ScholarÂ
Yin, H. et al. Liquid biopsies in cancer. Mol. Biomed. 6, 18 (2025).
Google ScholarÂ
Amintas, S. et al. Circulating tumor cell clusters: united we stand divided we fall. Int. J. Mol. Sci. 21, 2653 (2020).
Kawaguchi, M. et al. Extracellular domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation. J. Biol. Chem. 295, 2640–2649 (2020).
Google ScholarÂ
Nguyen, N. T. B. et al. Lactate controls cancer stemness and plasticity through epigenetic regulation. Cell Metab. 37, 903–919.e10 (2025).
Google ScholarÂ
Choi, H. Y. et al. Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activities. Breast Cancer Res. 21, 6 (2019).
Google ScholarÂ
Schnoor, B. et al. Fibrinolytic platelet decoys reduce cancer metastasis by dissociating circulating tumor cell clusters. Adv. Healthc. Mater. 13, e2304374 (2024).
Google ScholarÂ
Liu, X. et al. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell 41, 272–287.e9 (2023).
Google ScholarÂ
Guo, X. et al. Proliferation capability of natural killer cells upon cytokines stimulation correlated negatively with serum lactate dehydrogenase level in coronary artery disease patients. Front. Immunol. 15, 1436747 (2024).
Google ScholarÂ
Rachidi, S. et al. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis. Sci. Immunol. 2, eaai7911 (2017).
Okorafor, C. C., Shastri, S., Wen, K. & Ebong, E. E. Mechanisms of triple-negative breast cancer extravasation: impact of the physical environment and endothelial glycocalyx. FASEB J. 38, e23785 (2024).
Google ScholarÂ
Sökeland, G. & Schumacher, U. The functional role of integrins during intra- and extravasation within the metastatic cascade. Mol. Cancer 18, 12 (2019).
Google ScholarÂ
Miles, F. L., Pruitt, F. L., van Golen, K. L. & Cooper, C. R. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin. Exp. Metastasis 25, 305–324 (2008).
Google ScholarÂ
Ward, Y. et al. Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration. Cell Rep. 23, 808–822 (2018).
Google ScholarÂ
Meng, S. et al. MCT4 and CD147 colocalize with MMP14 in invadopodia and support matrix degradation and invasion by breast cancer cells. J. Cell Sci. 137, jcs261608 (2024).
Cardone, R. A., Casavola, V. & Reshkin, S. J. The role of disturbed pH dynamics and the na+/H+ exchanger in metastasis. Nat. Rev. Cancer 5, 786–795 (2005).
Google ScholarÂ
van Horssen, R. et al. Cancer cell metabolism regulates extracellular matrix degradation by invadopodia. Eur. J. Cell Biol. 92, 113–121 (2013).
Google ScholarÂ
Li, H.-M. et al. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. J. Exp. Clin. Cancer Res. 36, 7 (2017).
Google ScholarÂ
Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8, 98–101 (1989).
Google ScholarÂ
Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820–827 (2005).
Google ScholarÂ
Jiang, C. et al. Lactate accumulation drives hepatocellular carcinoma metastasis through facilitating tumor-derived exosome biogenesis by Rab7A lactylation. Cancer Lett. 217636. https://doi.org/10.1016/j.canlet.2025.217636 (2025).
Mai, R.-Y. et al. Up-regulated ITGB4 promotes hepatocellular carcinoma metastasis by activating hypoxia-mediated glycolysis and cancer-associated fibroblasts. Eur. J. Pharmacol. 986, 177102 (2025).
Google ScholarÂ
Matsui, T. et al. Targeting acidic pre-metastatic niche in lungs by pH low insertion peptide and its utility for anti-metastatic therapy. Front. Oncol. 13, 1258442 (2023).
Google ScholarÂ
Morrissey, S. M. et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 33, 2040–2058.e10 (2021).
Google ScholarÂ
Wu, X. et al. Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling. Cancer Lett. 478, 93–106 (2020).
Google ScholarÂ
Qian, J. et al. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer. Cell Commun. Signal. 19, 9 (2021).
Google ScholarÂ
Ma, J. et al. P-cadherin mechanoactivates tumor-mesothelium metabolic coupling to promote ovarian cancer metastasis. Cell Rep. 44, 115096 (2025).
Google ScholarÂ
Schwalk, A. J. et al. Risk factors for and time to recurrence of symptomatic malignant pleural effusion in patients with metastatic non-small cell lung cancer with EGFR or ALK mutations. Chest 159, 1256–1264 (2021).
Google ScholarÂ
Doherty, J. R. & Cleveland, J. L. Targeting lactate metabolism for cancer therapeutics. J. Clin. Investig. 123, 3685–3692 (2013).
Google ScholarÂ
Damen, M. P. F., van Rheenen, J. & Scheele, C. L. G. J. Targeting dormant tumor cells to prevent cancer recurrence. FEBS J. 288, 6286–6303 (2021).
Google ScholarÂ
Kirkland, J. L. Tumor dormancy and disease recurrence. Cancer Metastasis Rev. 42, 9–12 (2023).
Google ScholarÂ
Shang, T. et al. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. J. Hematol. Oncol. J. Hematol. Oncol. 18, 32 (2025).
Google ScholarÂ
Chen, X., Chen, S. & Yu, D. Metabolic reprogramming of chemoresistant cancer cells and the potential significance of metabolic regulation in the reversal of cancer chemoresistance. Metabolites 10, 289 (2020).
Kobayashi, A. et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J. Exp. Med. 208, 2641–2655 (2011).
Google ScholarÂ
Rak, J., Milsom, C. & Yu, J. Vascular determinants of cancer stem cell dormancy—do age and coagulation system play a role? APMIS Acta Pathol. Microbiol. Immunol. Scand. 116, 660–676 (2008).
Google ScholarÂ
Zhang, S. et al. CAFs-derived lactate enhances the cancer stemness through inhibiting the MST1 ubiquitination degradation in OSCC. Cell Biosci. 14, 144 (2024).
Google ScholarÂ
Ippolito, L. et al. Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer. EMBO Rep. 25, 3506–3531 (2024).
Google ScholarÂ
Carlson, P. et al. Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy. Nat. Cell Biol. 21, 238–250 (2019).
Google ScholarÂ
Wei, L. et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol. Cancer 19, 62 (2020).
Google ScholarÂ
Zhao, H. et al. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma. Drug Resist. Updat. 74, 101084 (2024).
Google ScholarÂ
Song, X. et al. Targeting drug-tolerant cells: a promising strategy for overcoming acquired drug resistance in cancer cells. MedComm 4, e342 (2023).
Google ScholarÂ
Dou, X. et al. PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. Nat. Metab. 5, 1887–1910 (2023).
Google ScholarÂ
Han, H. et al. ALKBH5 suppresses m(6)a mRNA modification of FOXM1 to drive cetuximab resistance in KRAS-mutant colorectal cancer. Oncogene. https://doi.org/10.1038/s41388-025-03490-1 (2025).
Li, Y., Zhao, J. & Li, Y. New exploration of KRAS(G12D) inhibitors and the mechanisms of resistance. Exp. Hematol. Oncol. 14, 39 (2025).
Google ScholarÂ
Richiardone, E. et al. MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy. Cancer Lett. 598, 217091 (2024).
Google ScholarÂ
Qian, Y. et al. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma. Cancer Cell 41, 1363–1380.e7 (2023).
Google ScholarÂ
Ta, W. et al. Three-dimensional dynamic blood-brain barrier model incorporating native cell culture systems based on shape memory biomaterials. Adv. Healthc. Mater. e2500066. https://doi.org/10.1002/adhm.202500066 (2025).
Tan, Z. et al. Bisecting GlcNAc modification reverses the chemoresistance via attenuating the function of P-gp. Theranostics 14, 5184–5199 (2024).
Google ScholarÂ
Iatsenko, I., Boquete, J.-P. & Lemaitre, B. Microbiota-derived lactate activates production of reactive oxygen species by the intestinal NADPH oxidase nox and shortens Drosophila lifespan. Immunity 49, 929–942.e5 (2018).
Google ScholarÂ
Ciszewski, W. M., Sobierajska, K., Stasiak, A. & Wagner, W. Lactate drives cellular DNA repair capacity: role of lactate and related short-chain fatty acids in cervical cancer chemoresistance and viral infection. Front. Cell Dev. Biol. 10, 1012254 (2022).
Google ScholarÂ
Wagner, W., Ciszewski, W. M. & Kania, K. D. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation. Cell Commun. Signal. 13, 36 (2015).
Google ScholarÂ
Watanabe, K. et al. Metabolically inducing defects in DNA repair sensitizes BRCA-wild-type cancer cells to replication stress. Sci. Signal. 17, eadl6445 (2024).
Google ScholarÂ
Zhang, K., Guo, L., Li, X., Hu, Y. & Luo, N. Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis. J. Transl. Med. 23, 247 (2025).
Google ScholarÂ
Zhang, C. et al. Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop. Oncogene. https://doi.org/10.1038/s41388-025-03318-y (2025).
Song, M., Liu, B., Wang, H. & Sun, W. Lactate metabolism and lactylation modification: new opportunities and challenges in cardiovascular disease. MedComm 6, e70269 (2025).
Google ScholarÂ
Luo, M. et al. Lactate increases tumor malignancy by promoting tumor small extracellular vesicles production via the GPR81-cAMP-PKA-HIF-1α axis. Front. Oncol. 12, 1036543 (2022).
Google ScholarÂ
Chen, P. et al. GPR132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis. Proc. Natl. Acad. Sci. USA 114, 580–585 (2017).
Google ScholarÂ
Lee, D. C. et al. A lactate-induced response to hypoxia. Cell 161, 595–609 (2015).
Google ScholarÂ
Xie, B. et al. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol. Cancer 22, 151 (2023).
Google ScholarÂ
Courtnay, R. et al. Cancer metabolism and the warburg effect: the role of HIF-1 and PI3K. Mol. Biol. Rep. 42, 841–851 (2015).
Google ScholarÂ
Liberti, M. V. & Locasale, J. W. The warburg effect: how does it benefit cancer cells? Trends Biochem. Sci. 41, 211–218 (2016).
Google ScholarÂ
Tian, L.-Y. et al. All three AKT isoforms can upregulate oxygen metabolism and lactate production in human hepatocellular carcinoma cell lines. Int. J. Mol. Sci. 25, 2168 (2024).
Chaudagar, K. et al. Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer. Clin. Cancer Res. 29, 1952–1968 (2023).
Google ScholarÂ
Wei, S. et al. Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma. Cell Death Discov. 10, 121 (2024).
Google ScholarÂ
Ruan, G.-X. & Kazlauskas, A. Lactate engages receptor tyrosine kinases axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase/akt and promote angiogenesis. J. Biol. Chem. 288, 21161–21172 (2013).
Google ScholarÂ
Guo, P., Wan, S. & Guan, K.-L. The hippo pathway: organ size control and beyond. Pharmacol. Rev. 77, 100031 (2025).
Google ScholarÂ
Zhou, J. et al. GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway. Oncogene 42, 3319–3330 (2023).
Google ScholarÂ
Huang, T. et al. Lactate-fueled oxidative metabolism drives DNA methyltransferase 1-mediated transcriptional co-activator with PDZ binding domain protein activation. Cancer Sci. 111, 186–199 (2020).
Google ScholarÂ
Lu, Y. et al. Lactate drives CD38 signaling to promote epithelial-mesenchymal transition through snail induction in non-small cell lung cancer cells. J. Cell Commun. Signal. 18, e12018 (2024).
Google ScholarÂ
Ke, R., Kumar, S., Singh, S. K., Rana, A. & Rana, B. Molecular insights into the role of mixed lineage kinase 3 in cancer hallmarks. Biochim. Biophys. Acta Rev. Cancer 1879, 189157 (2024).
Google ScholarÂ
Park, H. & Jeoung, N. H. Inflammation increases pyruvate dehydrogenase kinase 4 (PDK4) expression via the jun N-terminal kinase (JNK) pathway in C2C12 cells. Biochem. Biophys. Res. Commun. 469, 1049–1054 (2016).
Google ScholarÂ
Sangsuwan, R. et al. Identification of signaling networks associated with lactate modulation of macrophages and dendritic cells. Heliyon 11, e42098 (2025).
Google ScholarÂ
Arias-Betancur, A. et al. Deregulation of lactate permeability using a small-molecule transporter (lactrans-1) disturbs intracellular pH and triggers cancer cell death. Biochem. Pharmacol. 229, 116469 (2024).
Google ScholarÂ
Chaudagar, K. et al. Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. Clin. Cancer Res. 29, 4930–4940 (2023).
Google ScholarÂ
Sprowl-Tanio, S. et al. Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer. Cancer Metab. 4, 20 (2016).
Google ScholarÂ
Lecarpentier, Y., Claes, V., Vallée, A. & Hébert, J.-L. Thermodynamics in cancers: Opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway. Clin. Transl. Med. 6, 14 (2017).
Google ScholarÂ
Miao, Z., Zhao, X. & Liu, X. Hypoxia induced β-catenin lactylation promotes the cell proliferation and stemness of colorectal cancer through the Wnt signaling pathway. Exp. Cell Res. 422, 113439 (2023).
Google ScholarÂ
Fan, Z. et al. Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8(+) T-cell response by activating the wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance. Int. Immunopharmacol. 137, 112461 (2024).
Google ScholarÂ
Xiong, J. et al. Lactylation-driven METTL3-mediated RNA m(6)a modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol. Cell 82, 1660–1677.e10 (2022).
Google ScholarÂ
Valle-Mendiola, A. et al. STAT5 is necessary for the metabolic switch induced by IL-2 in cervical cancer cell line SiHa. Int. J. Mol. Sci. 25, 6835 (2024).
Wang, Y. et al. BACH1 changes microglial metabolism and affects astrogenesis during mouse brain development. Dev. Cell 59, 108–124.e7 (2024).
Google ScholarÂ
Du, S. et al. APOM modulates the glycolysis process in liver cancer cells by controlling the expression and activity of HK2 via the notch pathway. Biochem. Genet. https://doi.org/10.1007/s10528-024-11013-y (2025).
Xu, Y., Jiang, S., Hu, Y., Zhang, Q. & Su, W. TGF-β3 induces lactate production in Sertoli cell through inhibiting the notch pathway. Andrology 10, 1644–1659 (2022).
Google ScholarÂ
Zhi, X., Jiang, S., Zhang, J. & Qin, J. Ubiquitin-specific peptidase 24 accelerates aerobic glycolysis and tumor progression in gastric carcinoma through stabilizing PLK1 to activate NOTCH1. Cancer Sci. 114, 3087–3100 (2023).
Google ScholarÂ
Zhao, J.-L. et al. Notch-mediated lactate metabolism regulates MDSC development through the Hes1/MCT2/c-jun axis. Cell Rep. 38, 110451 (2022).
Google ScholarÂ
Kuwabara, S., Yamaki, M., Yu, H. & Itoh, M. Notch signaling regulates the expression of glycolysis-related genes in a context-dependent manner during embryonic development. Biochem. Biophys. Res. Commun. 503, 803–808 (2018).
Google ScholarÂ
Slaninova, V. et al. Notch stimulates growth by direct regulation of genes involved in the control of glycolysis and the tricarboxylic acid cycle. Open Biol. 6, 150155 (2016).
Google ScholarÂ
Gu, J. et al. Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation. Oncogene 43, 2389–2404 (2024).
Google ScholarÂ
Xue, Q. et al. Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion. J. Immunother. Cancer 12, e010040 (2024).
Qiu, M.-Z. et al. Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer. Signal Transduct. Target. Ther. 9, 349 (2024).
Google ScholarÂ
Wu, F. et al. TGF-βRII regulates glucose metabolism in oral cancer-associated fibroblasts via promoting PKM2 nuclear translocation. Cell Death Discov. 8, 3 (2022).
Google ScholarÂ
Longhitano, L. et al. Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma. Cancer Immunol. Immunother. 72, 1–20 (2023).
Google ScholarÂ
Chen, Y. et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology 143, 1319–1329.e11 (2012).
Google ScholarÂ
Li, D. et al. The role of myocardial energy metabolism perturbations in diabetic cardiomyopathy: From the perspective of novel protein post-translational modifications. Clin. Epigenetics 17, 15 (2025).
Google ScholarÂ
Jiang, Z. et al. PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression. Protein Cell 16, 49–63 (2025).
Google ScholarÂ
Guertin, D. A. & Wellen, K. E. Acetyl-CoA metabolism in cancer. Nat. Rev. Cancer 23, 156–172 (2023).
Google ScholarÂ
Varner, E. L. et al. Quantification of lactoyl-CoA (lactyl-CoA) by liquid chromatography mass spectrometry in mammalian cells and tissues. Open Biol. 10, 200187 (2020).
Google ScholarÂ
Majd, H., King, M. S., Smith, A. C. & Kunji, E. R. S. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis. Biochim. Biophys. Acta Bioenerg. 1859, 1–7 (2018).
Google ScholarÂ
Izzo, L. T. & Wellen, K. E. Histone lactylation links metabolism and gene regulation. Nature 574, 492–493 (2019).
Google ScholarÂ
Tachaveeraphong, W. & Phattarataratip, E. The significance of modified histone H3 in epithelial dysplasia and oral cancer. Int. Dent. J. 74, 769–776 (2024).
Google ScholarÂ
Sharma, D., Singh, M. & Rani, R. Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics. Semin. Cancer Biol. 87, 184–195 (2022).
Google ScholarÂ
Billiard, J. et al. Quinoline 3-sulfonamides inhibit lactate dehydrogenase a and reverse aerobic glycolysis in cancer cells. Cancer Metab. 1, 19 (2013).
Google ScholarÂ
Mazzio, E., Mack, N., Badisa, R. B. & Soliman, K. F. A. Triple isozyme lactic acid dehydrogenase inhibition in fully viable MDA-MB-231 cells induces cytostatic effects that are not reversed by exogenous lactic acid. Biomolecules 11, 1751 (2021).
McCleland, M. L. et al. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. Clin. Cancer Res. 19, 773–784 (2013).
Google ScholarÂ
Zhu, S. et al. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics. Cancer Lett. 503, 240–248 (2021).
Google ScholarÂ
Long, L. et al. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery. J. Exp. Clin. Cancer Res. 42, 117 (2023).
Google ScholarÂ
Guo, C. et al. Pharmacological properties and derivatives of shikonin-a review in recent years. Pharmacol. Res. 149, 104463 (2019).
Google ScholarÂ
Pajak, B. et al. 2-deoxy-d-glucose and its analogs: from diagnostic to therapeutic agents. Int. J. Mol. Sci. 21, 234 (2019).
Liu, X. et al. GSH-responsive nanoprodrug to inhibit glycolysis and alleviate immunosuppression for cancer therapy. Nano Lett. 21, 7862–7869 (2021).
Google ScholarÂ
Nath, K. et al. Mechanism of antineoplastic activity of lonidamine. Biochim. Biophys. Acta 1866, 151–162 (2016).
Google ScholarÂ
Forster, R. et al. Lonidamine: a non-mutagenic antitumor agent. Carcinogenesis 11, 1509–1515 (1990).
Google ScholarÂ
Jayabalan, N. et al. A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation. Drugs 83, 389–402 (2023).
Google ScholarÂ
Kobayashi, M., Narumi, K., Furugen, A. & Iseki, K. Transport function, regulation, and biology of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4). Pharmacol. Ther. 226, 107862 (2021).
Google ScholarÂ
Barbato, A. et al. Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma. Cell Prolif. 56, e13388 (2023).
Google ScholarÂ
Quanz, M. et al. Preclinical efficacy of the novel monocarboxylate transporter 1 inhibitor BAY-8002 and associated markers of resistance. Mol. Cancer Ther. 17, 2285–2296 (2018).
Google ScholarÂ
Van der Vreken, A. et al. Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis. J. Pathol. 260, 112–123 (2023).
Google ScholarÂ
Zhang, J. et al. Letter to the editor: atezolizumab plus bevacizumab for hepatocellular carcinoma in the real world. Hepatology 76, E84–E85 (2022).
Google ScholarÂ
Zhang, Q. et al. Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases. Gut Microbes 17, 2508426 (2025).
Google ScholarÂ
Wang, H. et al. PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. Clin. Transl. Med. 14, e70045 (2024).
Google ScholarÂ
Nicosia, L. et al. Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies. Cancer Cell 41, 2136–2153.e13 (2023).
Google ScholarÂ
Welti, J. et al. Targeting the p300/CBP axis in lethal prostate cancer. Cancer Discov. 11, 1118–1137 (2021).
Google ScholarÂ
Zu, H. et al. SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. Cell Discov. 8, 54 (2022).
Google ScholarÂ
Chen, J. et al. Lactylated apolipoprotein C-II induces immunotherapy resistance by promoting extracellular lipolysis. Adv. Sci. 11, e2406333 (2024).
Google ScholarÂ
Certo, M., Tsai, C.-H., Pucino, V., Ho, P.-C. & Mauro, C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat. Rev. Immunol. 21, 151–161 (2021).
Google ScholarÂ
Yu, W. et al. Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway. Chem. Biol. Interact. 387, 110816 (2024).
Google ScholarÂ
Colbert, L. E. et al. Tumor-resident lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell 41, 1945–1962.e11 (2023).
Google ScholarÂ
Li, J., Pan, J., Wang, L., Ji, G. & Dang, Y. Colorectal cancer: pathogenesis and targeted therapy. MedComm 6, e70127 (2025).
Google ScholarÂ
McGrail, K. et al. BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS(Q61)-mutated melanomas to targeted therapy. Nat. Commun. 13, 7113 (2022).
Google ScholarÂ
Ma, R. et al. Dual roles of lactate in EGFR-TKI-resistant lung cancer by targeting GPR81 and MCT1. J. Oncol. 2022, 3425841 (2022).
Google ScholarÂ
Zhou, Y. et al. Epigallocatechin gallate circumvents drug-induced resistance in non-small-cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis. Phytother. Res. 37, 5837–5853 (2023).
Google ScholarÂ
Yao, Y. et al. A novel nanozyme to enhance radiotherapy effects by lactic acid scavenging, ROS generation, and hypoxia mitigation. Adv. Sci. 11, e2403107 (2024).
Google ScholarÂ
Deng, H. et al. Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer. Nat. Commun. 16, 2597 (2025).
Google ScholarÂ
Dong, Q. et al. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells. Cell Commun. Signal. 18, 167 (2020).
Google ScholarÂ
Liu, K. X., Everdell, E., Pal, S., Haas-Kogan, D. A. & Milligan, M. G. Harnessing lactate metabolism for radiosensitization. Front. Oncol. 11, 672339 (2021).
Google ScholarÂ
Pandkar, M. R., Sinha, S., Samaiya, A. & Shukla, S. Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression. Transl. Oncol. 37, 101758 (2023).
Google ScholarÂ
Li, F. et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist. Updat. 73, 101059 (2024).
Google ScholarÂ
Zang, Y. et al. Hypoxia promotes histone H3K9 lactylation to enhance LAMC2 transcription in esophageal squamous cell carcinoma. iScience 27, 110188 (2024).
Google ScholarÂ
Wang, R. et al. H3K9 lactylation in malignant cells facilitates CD8(+) T cell dysfunction and poor immunotherapy response. Cell Rep. 43, 114686 (2024).
Google ScholarÂ
Huang, J. et al. Histone lactylation drives liver cancer metastasis by facilitating NSF1-mediated ferroptosis resistance after microwave ablation. Redox Biol. 81, 103553 (2025).
Google ScholarÂ
Liao, J. et al. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1. Int. J. Biol. Sci. 19, 5218–5232 (2023).
Google ScholarÂ
Duan, W. et al. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. J. Transl. Med. 21, 547 (2023).
Google ScholarÂ
Liu, M. et al. LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma. Cancer Lett. 595, 217025 (2024).
Google ScholarÂ
Zheng, P. et al. Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinoma. Cancer Cell Int. 23, 222 (2023).
Google ScholarÂ
Zhang, C. et al. H3K18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 84, 3589–3601 (2024).
Google ScholarÂ
Li, M. et al. Hypoxia conduces the glioma progression by inducing M2 macrophage polarization via elevating TNFSF9 level in a histone-lactylation-dependent manner. Am. J. Physiol. Cell Physiol. 327, C487–C504 (2024).
Google ScholarÂ
Duan, Y. et al. Integrated lactylome characterization reveals the molecular dynamics of protein regulation in gastrointestinal cancers. Adv. Sci. 11, e2400227 (2024).
Google ScholarÂ
Cheng, Z., Huang, H., Li, M. & Chen, Y. Proteomic analysis identifies PFKP lactylation in SW480 colon cancer cells. iScience 27, 108645 (2024).
Google ScholarÂ
Meng, Q. et al. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation. Redox Biol. 71, 103108 (2024).
Google ScholarÂ
Sun, K. et al. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J. Clin. Investig. e187024 https://doi.org/10.1172/JCI187024 (2025).
Huang, Y. et al. Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. J. Cell Biol. 223, e202308099 (2024).
Mi, J., Zhao, L., Shen, Y., Mo, S. & Kuang, Y. PFKP lactylation promotes the ovarian cancer progression through targeting PTEN. Biochem. Genet. https://doi.org/10.1007/s10528-024-10990-4 (2024).
Zhao, Z., Han, F., Yang, S., Wu, J. & Zhan, W. Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the akt-mTOR signaling pathway. Cancer Lett. 358, 17–26 (2015).
Google ScholarÂ
Maftouh, M. et al. Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. Br. J. Cancer 110, 172–182 (2014).
Google ScholarÂ
Wu, H. et al. Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli. Signal Transduct. Target. Ther. 6, 242 (2021).
Google ScholarÂ
Manerba, M. et al. Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells. Eur. J. Pharm. Sci. 96, 37–44 (2017).
Google ScholarÂ
Galloway, A., Hofstede, B. T. & Walsh, A. J. Fluorescence lifetime imaging microscopy for metabolic analysis of LDHB inhibition in triple negative breast cancer. Preprint at https://doi.org/10.1101/2025.01.13.632864 (2025).
Guo, Z. et al. Natural product fargesin interferes with H3 histone lactylation via targeting PKM2 to inhibit non-small cell lung cancer tumorigenesis. BioFactors 50, 592–607 (2024).
Google ScholarÂ
Park, J. H. et al. Specific pyruvate kinase M2 inhibitor, compound 3K, induces autophagic cell death through disruption of the glycolysis pathway in ovarian cancer cells. Int. J. Biol. Sci. 17, 1895–1908 (2021).
Google ScholarÂ
Goldberg, L., Israeli, R. & Kloog, Y. FTS and 2-DG induce pancreatic cancer cell death and tumor shrinkage in mice. Cell Death Dis. 3, e284 (2012).
Google ScholarÂ
Sang, R. et al. Degradation of hexokinase 2 blocks glycolysis and induces GSDME-dependent pyroptosis to amplify immunogenic cell death for breast cancer therapy. J. Med. Chem. 66, 8464–8483 (2023).
Google ScholarÂ
Cheng, G. et al. Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis. Nat. Commun. 10, 2205 (2019).
Google ScholarÂ
Oronsky, B. et al. RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist. Front. Oncol. 13, 1204143 (2023).
Google ScholarÂ
Wei, G. et al. The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy. Cell Metab. 33, 2021–2039.e8 (2021).
Google ScholarÂ
Ždralević, M. et al. Disrupting the ‘warburg effect’ re-routes cancer cells to OXPHOS offering a vulnerability point via ’ferroptosis’-induced cell death. Adv. Biol. Regul. 68, 55–63 (2018).
Google ScholarÂ
Khan, A. et al. Targeting metabolic activity in high-risk neuroblastoma through monocarboxylate transporter 1 (MCT1) inhibition. Oncogene 39, 3555–3570 (2020).
Google ScholarÂ
Andersen, A. P. et al. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment. Mol. Cancer 15, 45 (2016).
Google ScholarÂ
Li, N. et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc. Natl. Acad. Sci. USA 117, 20159–20170 (2020).
Google ScholarÂ
Dong, L. et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell 40, 70–87.e15 (2022).
Google ScholarÂ
Jin, J. et al. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. J. Exp. Clin. Cancer Res. 38, 377 (2019).
Google ScholarÂ
Pan, L. et al. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol. Res. 181, 106270 (2022).
Google ScholarÂ
